Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles

Interpreting the new stock of US stocks | It is difficult for high revenue growth to conceal the slowdown in profits, and AI and diversification are key to QMSK (QMSK.US) breaking through.

New stock news | Before the formal announcement, the Hong Kong Stock Exchange receives the disclosure.

BYD Company Limited (01211) will launch four new 210km large battery plug-in hybrid models, doubling the pure electric range.
Interpreting the new stock of US stocks | It is difficult for high revenue growth to conceal the slowdown in profits, and AI and diversification are key to QMSK (QMSK.US) breaking through.

New stock news | Before the formal announcement, the Hong Kong Stock Exchange receives the disclosure.

BYD Company Limited (01211) will launch four new 210km large battery plug-in hybrid models, doubling the pure electric range.

RECOMMEND

Patent Cliff Looms As Pharmaceutical Sector Prepares For A New Round Of Asset Competition
10/01/2026

Goldman Sachs Remains Bullish On China Equities: AI And Overseas Expansion To Drive Earnings, MSCI China Seen Rising 20% In 2026
10/01/2026

“A+H” Popularity Continues As Multiple A‑Share Companies Announce Hong Kong Listings At The Start Of The Year
10/01/2026


